osteoporosis

(redirected from Glucocorticoid-induced osteoporosis)
Also found in: Thesaurus, Medical, Encyclopedia.

os·te·o·po·ro·sis

 (ŏs′tē-ō-pə-rō′sĭs)
n. pl. os·te·o·po·ro·ses (-sēz)
A disease characterized by a decrease in bone mass and density, occurring especially in postmenopausal women, resulting in a predisposition to fractures.

[New Latin : osteo- + Greek poros, passage, pore; see pore2 + -osis.]

os′te·o·po·rot′ic (-rŏt′ĭk) adj.

osteoporosis

(ˌɒstɪəʊpɔːˈrəʊsɪs)
n
(Pathology) porosity and brittleness of the bones due to loss of calcium from the bone matrix
[C19: from osteo- + pore2 + -osis]
ˌosteopoˈrotic adj

os•te•o•po•ro•sis

(ˌɒs ti oʊ pəˈroʊ sɪs)

n.
a disorder in which the bones become increasingly porous, brittle, and subject to fracture, owing to loss of calcium and other mineral components.
[1840–50; osteo- + Greek pór(os) passage, pore2 + -osis]
os`te•o•po•rot′ic (-ˈrɒt ɪk) adj.

os·te·o·po·ro·sis

(ŏs′tē-ō-pə-rō′sĭs)
A condition in which the bones become porous and weak from loss of minerals, especially calcium.

osteoporosis

the rarefaction of bone, resulting in abnormally porous and weak bony tissue.
See also: Body, Human, Bones

osteoporosis

A group of diseases in which the resorption of bone outpaces the deposit of bone. Bones become lighter and more porous, making them susceptible to fracture.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.osteoporosis - abnormal loss of bony tissue resulting in fragile porous bones attributable to a lack of calcium; most common in postmenopausal women
pathology - any deviation from a healthy or normal condition
dowager's hump - abnormal spinal curvature that results when osteoporosis causes the spine to collapse; seen most often in elderly women
Translations
osteoporóza
luukatoosteoporoosi
csontritkulás

osteoporosis

[ˌɒstɪəʊpɔːˈrəʊsɪs] Nosteoporosis f inv

osteoporosis

[ˌɒstiəʊpəˈrəʊsɪs] nostéoporose f

os·te·o·po·ro·sis

n. osteoporosis, pérdida en la densidad del hueso.

osteoporosis

n osteoporosis f
References in periodicals archive ?
M2 PHARMA-October 11, 2017-FDA to Review sBLA for Prolia in Glucocorticoid-Induced Osteoporosis
Additionally, data will be presented from the Phase 3 study in patients with glucocorticoid-induced osteoporosis (GiOP), as well as data demonstrating that treatment with Prolia prevents deterioration in the trabecular microstructure at the distal tibia.
Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway.
The research team led by Professor Lyu and Professor Zhang further found that the aberrant elevated "CKIP-1" expression in osteoblasts could inhibit bone formation and contribute to the reduction in bone formation during ageing as well as in the development of glucocorticoid-induced osteoporosis.
There are limited fracture data for men and cases involving glucocorticoid-induced osteoporosis.
WASHINGTON -- New American College of Rheumatology recommendations for glucocorticoid-induced osteoporosis prevention and treatment include refinements in risk assessment and treatment.
We are excited that these data support the potential for Prolia use in patients with glucocorticoid-induced osteoporosis, the most common drug-induced form of the disease.
Glucocorticoid-induced osteoporosis in children: impact of the underlying disease.
It is well known that long-term administration of excessive glucocorticoid (GC) leads to glucocorticoid-induced osteoporosis (GIO), a vital risk factor of the increase in the incidence of bone fracture [1].
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis," Osteoporosis International, vol.
American College of Rheumatology 2010 recommendations forthe prevention and treatment of glucocorticoid-induced osteoporosis.
Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2014

Full browser ?